Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding.

Unson CG, Cypess AM, Wu CR, Goldsmith PK, Merrifield RB, Sakmar TP.

Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):310-5.

2.
3.

Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.

Unson CG, Wu CR, Jiang Y, Yoo B, Cheung C, Sakmar TP, Merrifield RB.

Biochemistry. 2002 Oct 1;41(39):11795-803.

PMID:
12269822
4.
5.

Positively charged residues at positions 12, 17, and 18 of glucagon ensure maximum biological potency.

Unson CG, Wu CR, Cheung CP, Merrifield RB.

J Biol Chem. 1998 Apr 24;273(17):10308-12.

6.

Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes.

Hjorth SA, Adelhorst K, Pedersen BB, Kirk O, Schwartz TW.

J Biol Chem. 1994 Dec 2;269(48):30121-4.

7.

Epitope mapping of the alpha-chain of the insulin-like growth factor I receptor using antipeptide antibodies.

Delafontaine P, Ku L, Ververis JJ, Cohen C, Runge MS, Alexander RW.

J Mol Cell Cardiol. 1994 Dec;26(12):1659-73.

PMID:
7731060
8.

Human glucagon receptor monoclonal antibodies: antagonism of glucagon action and use in receptor characterization.

Buggy J, Rossomando A, MacDougall M, Mierz D, Wunderlich D, Yoo-Warren H.

Horm Metab Res. 1996 May;28(5):215-9.

PMID:
8738108
9.
10.

Agonist-like activity of anti-peptide antibodies directed against an autoimmune epitope on the heart muscarinic acetylcholine receptor.

Fu ML, Gerd W, Ake H, Johan H.

Receptors Channels. 1994;2(2):121-30. Erratum in: Receptors Channels 1996;4(2):141.

PMID:
7525000
11.

Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus.

Runge S, Gram C, Brauner-Osborne H, Madsen K, Knudsen LB, Wulff BS.

J Biol Chem. 2003 Jul 25;278(30):28005-10. Epub 2003 Apr 29.

12.

Cloning and expression of a human glucagon receptor.

MacNeil DJ, Occi JL, Hey PJ, Strader CD, Graziano MP.

Biochem Biophys Res Commun. 1994 Jan 14;198(1):328-34.

PMID:
7507321
13.
14.

Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.

Dighe RR, Rojas FJ, Birnbaumer L, Garber AJ.

J Clin Invest. 1984 Apr;73(4):1013-23.

15.
16.

Identification of an essential serine residue in glucagon: implication for an active site triad.

Unson CG, Merrifield RB.

Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):454-8.

17.

Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.

McKee RL, Pelton JT, Trivedi D, Johnson DG, Coy DH, Sueiras-Diaz J, Hruby VJ.

Biochemistry. 1986 Apr 8;25(7):1650-6.

PMID:
3011069
18.

Characterization of glucagon receptors in Golgi fractions of rat liver: evidence for receptors that are uncoupled from adenylyl cyclase.

Lipson KE, Kolhatkar AA, Cherksey BD, Donner DB.

Biochemistry. 1986 May 6;25(9):2612-20.

PMID:
3013309
20.

Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies.

abu Alla S, Quitterer U, Grigoriev S, Maidhof A, Haasemann M, Jarnagin K, Müller-Esterl W.

J Biol Chem. 1996 Jan 19;271(3):1748-55.

Items per page

Supplemental Content

Write to the Help Desk